Project Grant F31DA062444

Award Date 6/24/25
Completion Date 12/31/27
Dollars Obligated $89K
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90095, USA
Similar Awards
This $180,646 Project Grant award, issued by the National Institute on Drug Abuse (NIDA) under the Federal Grant Program CFDA 93.279 - Drug Use and Addiction Research Programs, will support research to investigate the molecular mechanisms underlying astrocytic CREB's regulation of cocaine drug-seeking behavior. The research, to be conducted at the Icahn School of Medicine at Mount Sinai, aims to elucidate the astrocyte transcriptome and its epigenetic regulation in the context of drug addiction....
This Project Grant award of $201,250 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to investigate the role of astrocyte mitochondria bioenergetics in heroin-induced plasticity. The key products and services to be delivered through this 2-year award (8/1/2024 - 7/31/2026) include: Identifying the contribution of astrocyte mitochondria oxidative phosphorylation in mediating heroin-induced behavioral plasticity through...
This $403,542 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund research to profile the projection-specific proteome associated with the incubation of oxycodone craving. The research team at the University of Maryland, College Park will focus on the orbitofrontal cortex (OFC) to dorsal striatum (DS) neuronal projections. They aim to quantify proteome changes in the OFC neuronal somas (Aim 1) and...
This $373,300 Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), will support research to investigate the role of the nucleus accumbens (NAc) in learning and responding to reward-predictive cues. The research aims to enhance understanding of the neural activity dynamics in NAc that contribute to selective conditioned responses to reward-paired cues versus neutral cues. Using an auditory Pavlovian...
This $157,000 Project Grant award from the National Institute of Mental Health (NIMH) under CFDA Program 93.242 - Mental Health Research Grants supports research to investigate the role of dopamine receptor signaling in astrocytes and its impact on prefrontal cortex (PFC) functions. The key objectives are to determine how D2 dopamine receptor (D2R) signaling in astrocytes influences the activity of neighboring cells and induces microglia proliferation, which could impact PFC-dependent behaviors,...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,785,632.00 over a 5-year period starting on July 15, 2024 to the University of Pittsburgh. The award will support research aimed at elucidating the role of astrocytic dopamine signaling in the nucleus accumbens and its impact on cue-conditioned motivated behaviors and cocaine relapse. The key objectives include characterizing the...
This Project Grant award in the amount of $1,490,348 was provided by the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310). The funding supports a transformative research project titled "Astrocytes as the Integrators of Neuromodulator Signals" conducted by a multidisciplinary team of investigators. The key objective is to test the hypothesis that astrocytes, a common cell type in the brain, serve as integrators of...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $180,606 to the Icahn School of Medicine at Mount Sinai (ISMMS) to investigate the interplay between drug-induced long-term synaptic proteomic adaptations and underlying transcriptional responses within the brain's reward regions. The research aims to elucidate the cell-type and circuit-specific synaptic proteome changes in the nucleus...
The National Institute of Mental Health (NIMH) awarded a 5-year, $725,422 Project Grant (CFDA 93.242 - Mental Health Research Grants) to the Massachusetts Institute of Technology (MIT) to investigate the role of striatal astrocytes and the striato-nigro-striatal loop in modulating dopamine signals to facilitate transitions in behavioral states. The proposed research will utilize advanced techniques such as optogenetics, chemogenetics, and photometric imaging to study how astrocyte activity in...
This $751,043 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research investigating the cellular and molecular mechanisms underlying the complex co-occurrence of opioid use disorder (OUD), major depressive disorder (MDD), and HIV in the human brain. The award will fund a comprehensive study using advanced multi-omics approaches, including single-nucleus RNA sequencing and single-nucleus ATAC...

FUNCTIONS AND MECHANISMS OF CRYM-POSITIVE ASTROCYTES IN THE NUCLEUS ACCUMBENS - PROJECT SUMMARY/ABSTRACT ASTROCYTES ARE UBIQUITOUS CNS CELLS THAT MAKE EXTENSIVE CONTACTS WITH NEURONS. ASTROCYTES SERVE DIVERSE ROLES, INCLUDING ION HOMEOSTASIS, NEUROTRANSMITTER CLEARANCE, AND CONTRIBUTIONS TO NEUROVASCULAR COUPLING, WHICH POSITION THEM AS CRITICAL COMPONENTS OF NEURAL CIRCUITS THAT CONTRIBUTE TO BRAIN PHYSIOLOGY AND DISEASE. ONCE THOUGHT OF AS HOMOGENEOUS, RECENT STUDIES HAVE HIGHLIGHTED ASTROCYTE HETEROGENEITY ACROSS AND WITHIN BRAIN REGIONS. AS TOOLS TO STUDY ASTROCYTES HAVE IMPROVED, ONE IMPORTANT GOAL IS TO DETERMINE IF DEFINED POPULATIONS OF ASTROCYTES REGULATE BEHAVIORS ASSOCIATED WITH THE BRAIN REGION THEY ARE LOCATED IN. AN IDEAL POPULATION TO EXPLORE THIS LARGER QUESTION IS THE NEWLY DISCOVERED SUBPOPULATION OF CRYM+ ASTROCYTES WITHIN THE NUCLEUS ACCUMBENS (NAC), A STRUCTURE WITHIN THE VENTRAL STRIATUM THAT IS WELL CHARACTERIZED IN THE CONTEXT OF REWARDING BEHAVIORS AND ADDICTION. THE FOCUS OF THIS APPLICATION IS THUS TO DETERMINE THE ROLE(S) OF CRYM+ ASTROCYTES IN BEHAVIORS RELEVANT TO THE NAC. CRYM ENCODES THE PROTEIN M- CRYSTALLIN THAT WAS RECENTLY IDENTIFIED IN A SPECIFIC POPULATION OF CENTRAL STRIATAL ASTROCYTES TO REGULATE PERSEVERATIVE BEHAVIORS OF MICE. THE CURRENT APPLICATION SEEKS TO ELUCIDATE THE FUNCTIONS OF CRYM+ NAC ASTROCYTES (~45%) USING INTEGRATED MOLECULAR, CELLULAR, AND PHYSIOLOGICAL ASSESSMENTS DURING NATURAL BEHAVIORS AND A MODEL OF FENTANYL-EVOKED OPIOID USE DISORDER (OUD). I WILL TEST THE HYPOTHESIS THAT ASTROCYTES IN THE NAC HAVE SEPARABLE PROPERTIES RELATIVE TO THE DORSAL STRIATUM, CONTRIBUTE TO GOAL- DIRECTED BEHAVIORS, AND THAT THEY ARE ALTERED IN A CLINICALLY RELEVANT MODEL OF OPIOID USE DISORDER (OUD) WHERE GOAL-DIRECTED BEHAVIORS ARE DISRUPTED. THIS HYPOTHESIS IS BASED ON EXCITING PRELIMINARY DATA DESCRIBED IN THE APPLICATION, INCLUDING DATA SHOWING THAT CRYM EXPRESSION IS DECREASED IN NAC ASTROCYTES IN THE OUD MODEL. I WILL TEST THIS HYPOTHESIS WITH THREE SPECIFIC AIMS. AIM 1 WILL CHARACTERIZE BASIC BIOLOGICAL PROPERTIES OF ASTROCYTES IN THE NAC. AIM 2 WILL ASSESS FUNCTIONS OF CRYM+ NAC ASTROCYTES DURING GOAL-DIRECTED BEHAVIORS. AIM 3 WILL DETERMINE HOW NAC ASTROCYTES ARE ALTERED IN A MODEL OF FENTANYL- EVOKED OUD. THE AIMS ARE LOGICALLY RELATED TO ADDRESS MY HYPOTHESIS BUT ARE NOT INTERDEPENDENT SO THAT SUCCESS IN ANY ONE IS NOT CONTINGENT ON THE OTHER. THE COMPLETION OF THE PROPOSED EXPERIMENTS WILL PROVIDE ME WITH RIGOROUS TRAINING IN STATE-OF-THE-ART METHODS AND ALLOW ME TO DIRECTLY ADDRESS THE FUNCTIONS OF A MOLECULARLY DEFINED POPULATION OF ASTROCYTES IN THE NAC.

Posted 12/24/24, 12:00 AM